Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Neoplasms 6Anxiety Disorders 4Uterine Neoplasms 2Prostatic Neoplasms 2Pain 2Ovarian Neoplasms 2Vomiting 1Uterine Cervical Neoplasms 1Urogenital Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pain, Procedural 1Motor Activity 1Mood Disturbances 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Gynecologic Cancer 1Fallopian Tube Neoplasms 1Depression 1Chronic Disease 1Cancer Pain 1Breast Neoplasms 1Anemia, Sickle Cell 1

Interventions

padeliporfin 5Nivolumab 3vedolizumab 2atezolizumab 2anlotinib 2Therapeutics 2Surveys and Questionnaires 2Riluzole 2Radiotherapy 2LDP-02 2Ipilimumab 2Infliximab 2Immunoglobulin G 2Genetic Testing 2Fecal Microbiota Transplantation 2Disulfides 2Carboplatin 2CT-P13 2tislelizumab 1relatlimab 1prednylidene 1pembrolizumab 1palladium-bacteriopheophorbide 1olaparib 1niraparib 1ixabepilone 1ferumoxtran-10 1enfortumab vedotin 1deltacortene 1darolutamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Urogenital Neoplasms × Imagery, Psychotherapy × Clear all
NCT02444195 2017-03-20

Guided Imagery in the Perioperative Period in Gynecologic Oncology Patients

University of Michigan

Phase NA Completed
130 enrolled
Gynecologic

Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Urogenital Neoplasms, Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡